Author links open overlay panel, , , , , , , Highlights•Gold(I) inhibits caspase-1
•DFT calculations predict gold, not ligand, dictates binding
•Crystal structure solved for two gold phosphite complexes
•Small alkyl and aryl phospine ligands on gold led to potent, low nM inhibition
AbstractCaspase-1 is a key enzyme in the inflammasome that turns on the inflammation cascade. It has been implicated in a variety of disease conditions, including gout, rheumatoid arthritis and inflammatory diseases. Gold complexes have long been studied for their anti-inflammatory properties. The active site of caspase-1 contains a cysteine thiolate, and given that sulfur is aurophilic, we hypothesized that gold complexes would inhibit caspase-1. In this work, we examined a series of gold(I) molecular species for inhibition of caspase-1. It was found that many of the complexes were effective inhibitors at the nanomolar range, with the most effective being PMe3AuCl (KI = 8 nM) and PPh3AuCl (KI = 9 nM). This highlights the value of gold(I) complexes as drug molecules that target cysteine-dependent proteins for disease states.
Graphical abstractGold(I) complexes containing thiols, alkyl and aryl phosphines, and phosphites as ligands were potent, low nM IC50 inhibitors of caspase-1.
Download: Download high-res image (143KB)Download: Download full-size imageKeywordsGold
Caspase-1
Metal-based drugs
Cysteine-dependent enzymes
View Abstract© 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Comments (0)